<DOC>
<DOCNO>EP-0659752</DOCNO> 
<TEXT>
<INVENTION-TITLE>
ANTIBACTERIAL AND ANTI-TUMOR EPOXIDE DERIVATE DC 114-A1
</INVENTION-TITLE>
<CLASSIFICATIONS>A61P3104	A61P3100	A61P3500	A61P3500	C07D49300	A61K3135	C07D49304	C12P1718	C12P1718	A61K3135	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61P	A61P	A61P	A61P	C07D	A61K	C07D	C12P	C12P	A61K	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61P31	A61P31	A61P35	A61P35	C07D493	A61K31	C07D493	C12P17	C12P17	A61K31	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
A novel substance DC114-A1 represented by formula (I). 

</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<DESCRIPTION>
The present invention relates to a novel substance
DC114-A1 which has antibacterial and anti-tumor activity
and is useful as antibacterial and anti-tumor agents.Compound DC114-C which has a skeleton related to the
present compound and which is represented by the following
formula (II):

has been known (EP-A-0429209).The present invention provides a novel substance
DC114-A1 having antibacterial and anti-tumor activity
which is represented by the following formula (I): 
This compound can be produced by culturing a
microorganism belonging to the genus Streptomyces.The present invention is described in detail below.The physicochemical properties of DC114-A1 are shown
below.
(1) Molecular weight: 548(2) Molecular formula: C29H24O11(3) Mass spectrum: High resolution FAB mass spectrum
(matrix: m-nitrobenzyl alcohol): m/z amu
   Found: 549.1402 (M+H)+
   Calculated for C29H25O11: 549.1397(4) Specific rotation: [α]D26 = -53.8°
(c = 0.03, acetone)(5) UV absorption spectrum (measured in methanol)
λmax(ε);
224.5 (18,000), 275.0 (32,100), 408.0 (7,800)(6) IR absorption spectrum (measured by the KBr method):
νmax cm-1; 3469, 1726, 1697, 1653, 1396, 1294, 1271,
1117, 1093.(7) 13C-NMR spectrum (100 MHz, DMSO-d6 solution): δ ppm
(multiplicity);
206.0(s), 195.0(s), 189.2(s), 178.1(s), 164.3(s),
158.4(s), 154.2(s), 138.5(s), 128.2(s), 127.5(s), 
125.0(s), 121.6(s), 120.8(d), 112.9(d), 110.8(d),
110.7(s), 75.3(d), 74.5(d), 64.2(d), 64.1(d),
63.9(s), 57.8(d), 57.1(s), 48.5(d), 43.7(t), 42.3(t),
22.9(q), 14.3(q), 12.5(q).(8) 1H-NMR spectrum (400 MHz, DMSO-d6 solution): δ ppm
[integration, multiplicity, coupling constant (Hz)];
12.34(1H, br.s), 8.18(1H, s), 7.83(1H, s), 6.46(1H,
s), 5.47(1H, m), 4.85(1H, dd, 11.4, 3.1), 4.51(1H,
dq, 6.7, 6.7), 4.43(1H, br.d, 6.7), 4.31(1H, s),
3.26(1H, ddd, 6.6, 4.1, 2.5), 3.19(1H, d, 6.6),
2.95(1H, t, 4.7), 2.88(1H, dd, 5.0, 2.5), 2.85(1H,
dd, 14.0, 11.4), 2.80(3H, d, 0.8), 2.57(1H, dd, 14.0,
3.1), 1.88(3H, s), 1.15(3H, d, 6.7).(9) Solubility:
Soluble in dimethylsulfoxide (DMSO), methanol and
acetone; sparingly soluble in water, ethyl acetate,
chloroform and n-hexane.(10) Color reaction:
Positive to the iodine test(11) Color and property of the substance:
Yellow powder(12) Thin layer chromatography:
silica gel thin layer (HPTLC plate Art. 15647,
produced by Merck & Co., Inc.)The Rf value obtained by using toluene:acetone
solution (2:1 v/v) as a developing solvent was 0.4.The Rf value obtained by using chloroform:methanol
(20:1 v/v) as a developing solvent was 0.6.After the development, the
</DESCRIPTION>
<CLAIMS>
Substance DC114-A1 which is represented by
the following formula (I):


A substance according to claim 1 for use as antibacterial
and anti-tumor agents.
</CLAIMS>
</TEXT>
</DOC>
